← All indications
Stem Cell Transplantation
The transfer of STEM CELLS from one individual to another within the same species (TRANSPLANTATION, HOMOLOGOUS) or between species (XENOTRANSPLANTATION), or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). The source and location of the stem cells determines their potency or pluripotency to differentiate into various cell types.
Subtype terms (3)
More specific conditions that are subtypes of Stem Cell Transplantation in the MeSH hierarchy.
- Cord Blood Stem Cell Transplantation
9 drugs (3 approved, 6 experimental)
- Hematopoietic Stem Cell Transplantation
230 drugs (147 approved, 83 experimental)
- Mesenchymal Stem Cell Transplantation
10 drugs (1 approved, 9 experimental)
Drugs by status
Phase 4 trials (3)
Phase 3 trials (6)
Phase 2 trials (34)
- azacitidine
- plerixafor
- lenalidomide
- fbta05
- fluorouracil
- tacrolimus
- imatinib
- naltrexone
- bone marrow derived mesenchymal stem cells
- autologous cd133+ stem cells
- allogeneic stem cells
- vitamin c
- pentostatin
- atorvastatin
- sirolimus
- arsenic trioxide
- cyclosporine
- mycophenolate
- stem cells
- alemtuzumab
- bortezomib
- allogeneic adipose derived mesenchymal stem cell
- decidual stromal cells
- mesna
- autologous mononuclear stem cell
- autologous mesenchymal stem cells
- rituximab
- thiotepa
- sargramostim
- nilotinib
- +4 more
Phase 1 trials (8)
Other trials (1)